Cyclosporine
Who holds supplier records for Cyclosporine? 13 organisations hold a current record for Cyclosporine: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (5), India (2), Netherlands (1), United States (1) and 4 other countries (4).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Cyclosporine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cyclosporine
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Cyclosporine expires 1 Apr 2042. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Cyclosporine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- TAPI NL BVNetherlandsActive DMF 13799, 12932 · latest filing Sept 1998
- Abbvie Inc.United StatesCEP Company GMP cert on recordActive DMF 13800 · latest filing Sept 1998
- CKD BIO CORPSouthCEPActive DMF 12214 · latest filing Oct 1996
- CONCORD BIOTECH LTDIndiaCEP Company GMP cert on recordActive DMF 23962 · latest filing Jul 2010
- CURIA ITALY SRLItalyCEP Company GMP cert on recordActive DMF 12949 · latest filing Apr 1998
- NORTH CHINA PHARMACEUTICAL HUASHENG CO LTDChinaCEP Company GMP cert on recordActive DMF 33946 · latest filing Jun 2019
- ZHEJIANG RUIBANG LABORATORIES INCChinaCEPActive DMF 13858, 28512 · latest filing Dec 2014
- Apotex Inc.CanadaActive DMF 13929 · latest filing Jan 1999
- FISHFA BIOGENICS (A DIV OF FISHFA RUBBERS LTD)IndiaActive DMF 42966 · latest filing Nov 2025
- FUJIAN KERUI PHARMACEUTICAL CO LTDChinaActive DMF 13789 · latest filing Sept 1998
- JOYANG LABORATORIESChinaActive DMF 18932 · latest filing Sept 2005
- TAPI Czech Industries s.r.oCzech RepublicCEP Company GMP cert on record
- JIANGSU JOYANG LABORATORIES CO. LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Cyclosporine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| JIANGSU JOYANG LABORATORIES CO. LTD. Yancheng | CN | CEP 2003-105 - Rev 04 Ciclosporin | Jul 2026 | Inspected Nov 2024 Germany |
| TAPI CZECH INDUSTRIES S.R.O. Opava | CZ | CEP 2002-152 - Rev 07 Ciclosporin | Mar 2025 | Inspected Oct 2024 Czechia |
| North China Pharmaceutical Huasheng Co., Ltd. Shijiazhuang | CN | CEP 2021-399 - Rev 00 Ciclosporin | Feb 2024 | Inspected Jun 2024 Netherlands |
| Zhejiang Ruibang Laboratories Wenzhou | CN | R0-CEP 2020-144 - Rev 00 Ciclosporin | Apr 2023 | — |
| CONCORD BIOTECH LIMITED Ahmedabad | IN | R1-CEP 2010-214 - Rev 03 Ciclosporin | Oct 2022 | — |
| CURIA ITALY S.R.L. Rozzano, Milano | IT | R1-CEP 1999-034 - Rev 06 Ciclosporin | Aug 2021 | — |
| CKD BIO CORPORATION Ansan-si | KR | R1-CEP 2007-251 - Rev 02 Ciclosporin | Aug 2021 | — |
| AbbVie Inc. North Chicago | US | R1-CEP 1998-093 - Rev 07 Ciclosporin | Oct 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Cyclosporine are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- WATSON LABORATORIES INCInactive DMF 15328 · filed Mar 2001
- NORTH CHINA PHARMACEUTICAL CORPInactive DMF 14315, 10281 · filed Jul 1998
- GALENA ASInactive DMF 11971 · filed May 1996
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (43 listed products contain Cyclosporine). The latest listed patent expires 1 Apr 2042. The latest listed exclusivity runs to 23 Jun 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Cyclosporine is a protein active pharmaceutical ingredient (ChEMBL CHEMBL160).
Chemical identity
- IUPAC name
- (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
- Canonical SMILES
- CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
- InChIKey
- PMATZTZNYRCHOR-CGLBZJNRSA-N
- Synonyms
- 27-400, ANTIBIOTIC S-7481F1, Atopica, Capimune, Capsorin, Cequa, Ciclosporin, Ciclosporin a, Ciclosporina, Ciclosporine, Ciclosporinum, Cyclosporin
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Calcineurin Inhibitor Immunosuppressant
- Mechanism of action
- Calcineurin Inhibitors; Cytochrome P450 3A4 Inhibitors; P-Glycoprotein Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Cyclosporine?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Cyclosporine: TAPI NL BV (Netherlands), Abbvie Inc. (United States), CKD BIO CORP (South), CONCORD BIOTECH LTD (India), CURIA ITALY SRL (Italy), NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD (China), ZHEJIANG RUIBANG LABORATORIES INC (China) and Apotex Inc. (Canada), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Cyclosporine Drug Master Files are active?
TAPI NL BV (DMF 13799, 12932), Abbvie Inc. (DMF 13800), CKD BIO CORP (DMF 12214), CONCORD BIOTECH LTD (DMF 23962), CURIA ITALY SRL (DMF 12949), NORTH CHINA PHARMACEUTICAL HUASHENG CO LTD (DMF 33946), ZHEJIANG RUIBANG LABORATORIES INC (DMF 13858, 28512) and Apotex Inc. (DMF 13929) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Cyclosporine records mean?
3 organisations have only inactive Type II DMFs for Cyclosporine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Cyclosporine have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Cyclosporine on the EDQM register, including JIANGSU JOYANG LABORATORIES CO. LTD. Yancheng (CN), TAPI CZECH INDUSTRIES S.R.O. Opava (CZ), North China Pharmaceutical Huasheng Co., Ltd. Shijiazhuang (CN), Zhejiang Ruibang Laboratories Wenzhou (CN), CONCORD BIOTECH LIMITED Ahmedabad (IN) and CURIA ITALY S.R.L. Rozzano, Milano (IT) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Cyclosporine?
Yes. The latest patent listed for an approved US product containing Cyclosporine expires 1 Apr 2042, across 43 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Cyclosporine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Cyclosporine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.